Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1Since this trial is focused on feasibility, acceptability, and appropriateness rather than directly measuring whether VR actually reduces anxiety or delirium outcomes, what does that mean for what we'd realistically learn or gain from participating?
2. 2Given that this study involves delivering virtual reality to critically ill ICU patients, what specific safety concerns have been identified around using VR headsets in that setting, such as infection risk, sensory overstimulation, or worsening agitation?
3. 3Since the trial is still in an early feasibility stage, is there any existing evidence my doctor finds convincing that VR could genuinely help with ICU anxiety or delirium, or is this still largely exploratory territory?
4. 4How would participating in this trial interact with or delay standard ICU care for managing agitation and delirium, such as sedation medications or other established protocols?
5. 5What kinds of patients are typically considered unsuitable for this type of VR intervention in the ICU, and are there any aspects of my specific condition that might make participation risky or impractical?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.